lifesciencesipreview3d
US agency warns 10 pharma companies of filing ‘bogus’ patents
AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in ...
lifesciencesipreview3d
BioNTech’s patent juggling act: protecting innovation amid IP challenges
Ahead of her panel discussion at LSPN North America, Kady Bruce shares insights into her role and how she ensures BioNTech’s ...
lifesciencesipreview3d
USPTO veteran joins Finnegan as of counsel in Washington, DC
Former senior legal advisor at USPTO brings wealth of life sciences experience | Move represents transition back into private practice after two decades. After almost 20 years at the US Patent and ...
lifesciencesipreview4d
CureVac and Acuitas wind up COVID-19 vaccine dispute
CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...
lifesciencesipreview4d
Amgen and Sandoz settle dispute over blockbuster bone condition drugs
Amgen has settled its patent infringement litigation with Sandoz, it was announced yesterday (April 29), with a deal that ...
lifesciencesipreview9d
GSK: Pfizer, BioNTech ‘reaped billions of dollars’ from stealing COVID-19 patents
New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of ...
lifesciencesipreview9d
GSK settles HIV drug licensing dispute
GSK subsidiary ViiV Healthcare and Exavir Therapeutics have settled their dispute over licensing rights for HIV drug ...
lifesciencesipreview9d
Bio-Techne loses UK patent bid and heads to UPC
UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims ...
lifesciencesipreview9d
Meeting the cell and gene therapy scale-up challenge
One of the pivotal challenges in the development and commercialisation of cell and gene therapies (CGT) lies in scaling up ...